DHR Health Institute for Research and Development Encourages Healthcare Workers Across the Rio Grande Valley to Join National PCORnet® Study to Fight COVID-19 Together

Translate to Spanish or other 102 languages!

HeroesResearch.org clinical research registry launches to answer crucial questions about the impact of novel coronavirus on healthcare workers’ lives

- Advertisement -

Mega Doctor News

Edinburg, TX   DHR Health Institute for Research and Development is proud to support the Healthcare Worker Exposure Response & Outcomes (HERO) Registry to join with other U.S. healthcare workers in sharing clinical and life experiences in order to understand the perspectives and problems faced by those on the COVID-19 pandemic front lines.  

The registry will unite America’s healthcare workers into a community to facilitate rapid-cycle research, including an upcoming large study of hydroxychloroquine’s effectiveness in preventing coronavirus infections in healthcare workers. The HERO research program leverages PCORnet®, the National Patient-Centered Clinical Research Network, and is funded by the Patient-Centered Outcomes Research Institute (PCORI).

- Advertisement -

The HERO Registry is asking hundreds of thousands of healthcare professionals to participate, including nurses, therapists, physicians, emergency responders, food service workers, environmental services workers, interpreters, and transporters – anyone who works in a setting where people receive health care.  

“We’re calling on healthcare workers in the Rio Grande Valley to share their perspectives so that we can understand and provide answers to the problems they face in real time – and over time,” said Manish Singh, MD, Chief Executive Officer, DHR Health. “This is the time to be proactive, to develop ways to stay safe on the front lines. I encourage everyone to be a part of HERO—and part of the solution.”

The goals of the registry are to engage healthcare workers in a research community, understand their experiences and interests through ongoing surveys, and track critical health outcomes associated with caring for patients with COVID-19, such as stress and burnout. The HERO Registry will help speed clinical studies that address unmet needs for healthcare workers.

“We have strong working partnership with PCORnet® to address major healthcare issues,” said Sohail Rao, MD, MA, DPhil, President and Chief Executive Officer, DHR Health Institute for Research and Development. “COVID-19 is a pandemic that our community is facing today and DHR Health and the DHR Health Institute for Research and Development is working with regional partners to meet this challenge.”

There is no cost to enroll in the HERO Registry and registration takes only a few minutes. Healthcare workers can participate as much or as little as they like in surveys and other opportunities. The registry will follow a protocol developed by the Duke Clinical Research Institute and data guidelines to keep healthcare worker information secure.

- Advertisement -

To learn more about the HERO Registry, visit https://heroesresearch.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Offers Advanced, Comprehensive Care for Scoliosis Patients–Early Detection is Key!

In recognition of “National Scoliosis Awareness Month” in June, DHR Health is reminding the community that comprehensive scoliosis care is available close to home through its Scoliosis Rehabilitation Clinic and Orthopedic Spine Center of Excellence.

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

Dr. Michael Seawell Discusses Renal Denervation for Difficult-to-Control High Blood Pressure

Dr. Michael Seawell, a board-certified interventional cardiologist at DHR Health, is helping expand access to renal denervation, a minimally invasive treatment designed for patients with difficult-to-control high blood pressure.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.
- Advertisement -